These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17454237)

  • 1. Addressing the needs of speakers with longstanding dysarthria: computerized and traditional therapy compared.
    Palmer R; Enderby P; Hawley M
    Int J Lang Commun Disord; 2007 Mar; 42 Suppl 1():61-79. PubMed ID: 17454237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of non-progressive dysarthria: practice patterns of speech and language therapists in the Republic of Ireland.
    Conway A; Walshe M
    Int J Lang Commun Disord; 2015; 50(3):374-88. PubMed ID: 25652223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-speech oro-motor exercise use in acquired dysarthria management: regimes and rationales.
    Mackenzie C; Muir M; Allen C
    Int J Lang Commun Disord; 2010; 45(6):617-29. PubMed ID: 20085536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The living with dysarthria group: implementation and feasibility of a group intervention for people with dysarthria following stroke and family members.
    Mackenzie C; Paton G; Kelly S; Brady M; Muir M
    Int J Lang Commun Disord; 2012; 47(6):709-24. PubMed ID: 23121529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auditory discrimination as a condition for E-learning based Speech Therapy: a proposal for an auditory discrimination test (ADT) for adult dysarthric speakers.
    Beijer LJ; Rietveld AC; van Stiphout AJ
    J Commun Disord; 2011; 44(6):701-18. PubMed ID: 21719027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automatic boost articulation therapy in adults with dysarthria: Acceptability, usability and user interaction.
    Mendoza Ramos V; Vasquez-Correa JC; Cremers R; Van Den Steen L; Nöth E; De Bodt M; Van Nuffelen G
    Int J Lang Commun Disord; 2021 Sep; 56(5):892-906. PubMed ID: 34227721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparing an E-learning-based Speech Therapy (EST) efficacy study: Identifying suitable outcome measures to detect within-subject changes of speech intelligibility in dysarthric speakers.
    Beijer LJ; Rietveld AC; Ruiter MB; Geurts AC
    Clin Linguist Phon; 2014 Dec; 28(12):927-50. PubMed ID: 25025268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.
    Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ
    Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitating use of speech recognition software for people with disabilities: a comparison of three treatments.
    Hird K; Hennessey NW
    Clin Linguist Phon; 2007 Mar; 21(3):211-26. PubMed ID: 17364626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Speech rate treatments for individuals with dysarthria: a tutorial.
    Blanchet PG; Snyder GJ
    Percept Mot Skills; 2010 Jun; 110(3 Pt 1):965-82. PubMed ID: 20681347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of smooth speech on the speech production of an individual with ataxic dysarthria.
    Stocks R; Dacakis G; Phyland D; Rose M
    Brain Inj; 2009 Sep; 23(10):820-9. PubMed ID: 19697171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electropalatography treatment for articulation impairment in children with dysarthria post-traumatic brain injury.
    Morgan A; Liegeois F; Occomore L
    Brain Inj; 2007 Oct; 21(11):1183-93. PubMed ID: 17896211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Be Clear: A New Intensive Speech Treatment for Adults With Nonprogressive Dysarthria.
    Park S; Theodoros D; Finch E; Cardell E
    Am J Speech Lang Pathol; 2016 Feb; 25(1):97-110. PubMed ID: 26882004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing speech supplementation strategies: effects on intelligibility and speech rate of individuals with chronic severe dysarthria.
    Hustad KC; Jones T; Dailey S
    J Speech Lang Hear Res; 2003 Apr; 46(2):462-74. PubMed ID: 14700386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating dysarthria following traumatic brain injury: investigating the benefits of commencing treatment during post-traumatic amnesia in two participants.
    McGhee H; Cornwell P; Addis P; Jarman C
    Brain Inj; 2006 Nov; 20(12):1307-19. PubMed ID: 17132553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of interutterance stability: application to dysarthria.
    Cummins F; Lowit A; van Brenk F
    J Speech Lang Hear Res; 2014 Feb; 57(1):81-9. PubMed ID: 24687469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Living with Dysarthria group for post-stroke dysarthria: the participant voice.
    Mackenzie C; Kelly S; Paton G; Brady M; Muir M
    Int J Lang Commun Disord; 2013; 48(4):402-20. PubMed ID: 23889836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive treatment of dysarthria secondary to stroke.
    Mahler LA; Ramig LO
    Clin Linguist Phon; 2012 Aug; 26(8):681-94. PubMed ID: 22774928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment of severe dysarthria: a case study.
    Simpson MB; Till JA; Goff AM
    J Speech Hear Disord; 1988 Nov; 53(4):433-40. PubMed ID: 2972886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural intervention effects in dysarthria following stroke: communication effectiveness, intelligibility and dysarthria impact.
    Mackenzie C; Lowit A
    Int J Lang Commun Disord; 2007; 42(2):131-53. PubMed ID: 17365091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.